Life sciences & healthcare
Click here to find out more
How UK-Israeli collaboration could change the face of global healthtech
9 February 2021
Quick read
by Josef Fuss and Nathan Krapivensky
Life sciences & healthcare
Click here to find out more
How to keep clinical trial data flowing under GDPR and after Brexit
8 February 2021
Briefing
Life sciences & healthcare
Click here to find out more
Edison Open House Global Healthcare 2021 – key takeaways from our panel
4 February 2021
Quick read
by multiple authors
Digital health
Click here to find out more
Digital Health 2021
26 January 2021
In-depth analysis
by multiple authors
Digital health
Click here to find out more
mHealth apps – top tips for GDPR compliance
26 January 2021
Briefing
UPC
Click here to find out more
New – presumably short – delay of the Unified Patent Court due to two constitutional complaints with expedited motions
22 January 2021
Briefing
by Dr. Gisbert Hohagen, Lic. en droit (Paris II/ Assas) and Dr. Philipp Krusemarck
Brexit
Click here to find out more
Brexit – what's the deal for business?
12 January 2021
Briefing
by multiple authors
Life sciences & healthcare
Click here to find out more
Will the UK government's COVID-19 dosing regime gamble pay off?
11 January 2021
Briefing
by Alison Dennis and Justyna Ostrowska
Life sciences & healthcare
Click here to find out more
One Nucleus Genesis Digital 2020 – Key takeaways from our cell and gene therapy panel session
6 January 2021
Quick read
Life sciences & healthcare
Click here to find out more
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
31 December 2020
Briefing
Brands & advertising
Click here to find out more
Novartis vs Bayer
A reminder to always substantiate claims in pharma ads
28 December 2020
Quick read
by Judith Krens and Marthe Riewald
Digital health
Click here to find out more
A new era for digital health in Germany
10 December 2020
Briefing